Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 5, 2003, Pages 1543-1554

  Gauthier, Christian ^a   Weber, Sandra ^a   Alarco, Anne Marie ^a,c   Alqawi, Omar ^b   Daoud, Roni ^b   Georges, Elias ^b   Raymond, Martine ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANTIFUNGAL AGENT; ASCOMYCIN; CARRIER PROTEIN; DIAMIDE; HYDROGEN PEROXIDE; IMMUNOSUPPRESSIVE AGENT; PROTEIN CDR1P; PROTEIN CDR2P; PYRROLE DERIVATIVE; RHODAMINE 123; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; DRUG SENSITIVITY; FUNGAL GENETICS; GENETIC CONSERVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SACCHAROMYCES CEREVISIAE; WESTERN BLOTTING;

ATP-BINDING CASSETTE TRANSPORTERS; BINDING SITES; CANDIDA ALBICANS; FUNGAL PROTEINS; MEMBRANE TRANSPORT PROTEINS; OXIDATIVE STRESS; SACCHAROMYCES CEREVISIAE; TACROLIMUS;

EID: 0038335066     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.5.1543-1554.2003     Document Type: Article

References (74)

1. Albertson, G. D., M. Niimi, R. D. Cannon, and H. F. Jenkinson. 1996. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob. Agents Chemother. 40:2835-2841.
2. Ambudkar, S. V., S. Dey, C. A. Hrycyna, M. Ramachandra, I. Pastan, and M. M. Gottesman. 1999. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39:361-398.
3. Arceci, R. J., K. Stieglitz, and B. E. Bierer. 1992. Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. Blood 80:1528-1536.
4. Arndt, C., M. C. Cruz, M. E. Cardenas, and J. Heitman. 1999. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. Microbiology 145:1989-2000.
5. Barchiesi, F., L. K. Najvar, M. F. Luther, G. Scalise, M. G. Rinaldi, and J. R. Graybill. 1996. Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine carididiasis model. Antimicrob. Agents Chemother. 40:1317-1320.
6. Bauer, B. E., H. Wolfger, and K. Kuchler. 1999. Inventory and function of yeast ABC proteins: about sex, stress, pleiotropic drug and heavy metal resistance. Biochim. Biophys. Acta 1461:217-236.
7. Becker, J. M., L. K. Henry, W. Jiang, and Y. Koltin. 1995. Reduced virulence of Candida albicans mutants affected in multidrug resistance. Infect. Immun. 63:4515-4518.
8. Berkower, C., and S. Michaelis. 1991. Mutational analysis of the yeast a-factor transporter STE6, a member of the ATP binding cassette (ABC) protein superfamily. EMBO J. 10:3777-3785.
9. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
10. Carreras, C. W., H. Fu, and D. V. Santi. 2001, An FKBP12 binding assay based upon biotinylated FKBP12. Anal. Biochem. 298:57-61.
11. Cruz, M. C., A. L. Goldstein, J. R. Blankenship, M. Del Poeta, D. Davis, M. E. Cardenas, J. R. Perfect, J. H. McCusker, and J. Heitman. 2002. Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J. 21:546-559.
12. Daoud, R., M. Julien, P. Gros, and E. Georges. 2001. Major photoaffinity drug binding sites in multidrug resistance protein 1 (MRP1) are within transmembrane domains 10-11 and 16-17. J. Biol. Chem. 276:12324-12330.
13. Daoud, R., C. Kast, P. Gros, and E. Georges. 2000. Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1). Biochemistry 39:15344-15352.
14. Decottignies, A., and A. Goffeau. 1997. Complete inventory of the yeast ABC proteins. Nat. Genet. 15:137-145.
15. Decottignies, A., A. M. Grant, J. W. Nichols, H. de Wet, D. B. McIntosh, and A. Goffeau. 1998. ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J. Biol. Chem. 273:12612-12622.
16. Decottignies, A., G. Owsianik, and M. Ghislain. 1999. Casein kinase 1-dependent phosphorylation and stability of the yeast multidrug transporter pdr5p. J. Biol. Chem. 274:37139-37146.
17. Del Poeta, M., M. C. Cruz, M. E. Cardenas, J. R. Perfect, and J. Heitman. 2000. Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. Antimicrob. Agents Chemother. 44:739-746.
18. De Micheli, M., J. Bille, C. Schueller, and D. Sanglard. 2002. A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol. Microbiol. 43:1197-1214.
19. Dey, S., M. Ramachandra, I. Pastan, M. M. Gottesman, and S. V. Ambudkar. 1998. Photoaffinity labeling of human P-glycoprotein: effect of modulator interaction and ATP hydrolysis on substrate binding. Methods Enzymol. 292:318-328.
20. Dixon, D. M., M. M. McNeil, M. L. Cohen, B. G. Gellin, and J. R. La Montagne. 1996. Fungal infections: a growing threat. Public Health Rep. 111:226-235.
21. Dumont, F. J. 2000. FK506, an immunosuppressant targeting calcineurin function. Curr. Med. Chem. 7:731-748.
22. Egner, R., and K. Kuchler. 1996. The yeast multidrug transporter Pdr5 of the plasma membrane is ubiquitinated prior to endocytosis and degradation in the vacuole. FEBS Lett. 378:177-181.
23. Egner, R., F. E. Rosenthal, A. Krani, D. Sanglard, and K. Kuchler. 1998. Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resisitance transporter. Mol. Biol. Cell 9:523-543.
24. Fetsch, E. E., and A. L. Davidson. 2002. From the cover: vanadate-catalyzed photocleavage of the signature motif of an ATP-binding cassette (ABC) transporter. Proc. Natl. Acad. Sci. USA 99:9685-9690.
25. Fonzi, W. A., and M. Y. Irwin. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728.
26. Franz, R., S. L. Kelly, D. C. Lamb, D. E. Kelly, M. Ruhnke, and J. Morschhauser. 1998. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob. Agents Chemother. 42:3065-3072.
27. Goshorn, A. K., and S. Scherer. 1989. Genetic analysis of prototrophic natural variants of Candida albicans. Genetics 123:667-673.
28. Graybill, J. R., E. Montalbo, W. R. Kirkpatrick, M. F. Luther, S. G. Revankar, and T. F. Patterson. 1998. Fluconazole versus Candida albicans: a complex relationship. Antimicrob. Agents Chemother. 42:2938-2942.
29. Greenberger, L. M. 1998. Identification of drug interaction sites in P-glycoprotein. Methods Enzymol. 292:307-317.
30. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
31. Hatanaka, H., T. Kino, S. Miyata, N. Inamura, A. Kuroda, T. Goto, H. Tanaka, and M. Okuhara. 1988. FR-900520 and FR-900523, novel immunosuppressants isolated from a Streptomyces. II. Fermentation, isolation and physico-chemical and biological characteristics. J. Antibiol. (Tokyo) 41:1592-1601.
32. Hemenway, C. S., and J. Heitman. 1999. Calcineurin. Structure, function, and inhibition. Cell Biochem. Biophys. 30:115-151.
33. Henry, K. W., M. C. Cruz, S. K. Katiyar, and T. D. Edlind. 1999. Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents. Antimicrob. Agents Chemother. 43:1968-1974.
34. Higgins, C. F. 1992. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8:67-113.
35. Hipfner, D. R., R. G. Deeley, and S. P. Cole. 1999, Structural, mechanistic and clinical aspects of MRP1. Biochim. Biophys. Acta 1461:359-376.
36. Ito, H., Y. Fukuda, K. Murata, and A. Kimura. 1983. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153:163-168.
37. Kohli, A., K. Smriti, A. Mukhopadhyay, R. Rattan, and R. Prasad. 2002. In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry. Antimicrob. Agents Chemother. 46:1046-1052.
38. Kontoyiannis, D. P. 2000. Efflux-mediated resistance to fluconazole could be modulated by sterol homeostasis in Saccharomyces cerevisiae. J. Antimicrob. Chemother. 46:199-203.
39. Kosower, N. S., and E. M. Kosower. 1995. Diamide: an oxidant probe for thiols. Methods Enzymol. 251:123-133.
40. Kralli, A., and K. R. Yamamoto. 1996. An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones. J. Biol. Chem. 271:17152-17156.
41. Krishnamurthy, S., V. Gupta, R. Prasad, and S. L. Panwar. 1998. Expression of CDR1, a multidrug resistance gene of Candida albicans: transcriptional activation by heat shock, drugs and human steroid hormones. FEMS Microbiol. Lett. 160:191-197.
42. Laemmli, U. K. 1970. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680-685.
43. Lopez-Ribot, J. L., R. K. McAtee, S. Perea, W. R. Kirkpatrick, M. G. Rinaldi, and T. F. Patterson. 1999. Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 43:1621-1630.
44. Maesaki, S., P. Marichal, M. A. Hossain, D. Sanglard, H. Vanden Bossche, and S. Kohno. 1998. Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains. J. Antimicrob. Chemother. 42:747-753.
45. Mahe, Y., Y. Lemoine, and K. Kuchler. 1996. The ATP binding cassette transporters Pdr5 and Snq2 of Saccharomyces cerevisiae can mediate transport of steroids in vivo. J. Biol. Chem. 271:25167-25172.
46. Milewski, S., F. Mignini, R. Prasad, and E. Borowski. 2001. Unusual susceptibility of a multidrug-resistant yeast strain to peptidic antifungals. Antimicrob. Agents Chemother. 45:223-228.
47. Mumberg, D., R. Muller, and M. Funk. 1995. Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene 156:119-122.
48. Murphy, J. W. 1991. Mechanisms of natural resistance to human pathogenic fungi. Annu. Rev. Microbiol. 45:509-538.
49. Nakamura, K., M. Niimi, K. Niimi, A. R. Holmes, J. E. Yates, A. Decottignies, B. C. Monk, A. Goffeau, and R. D. Cannon. 2001. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob. Agents Chemother. 45:3366-3374.
50. Nare, B., R. K. Prichard, and E. Georges. 1994. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells. Mol. Pharmacol. 45:1145-1152.
51. Nguyen, D. T., A. M. Alarco, and M. Raymond. 2000. Multiple Yap1pbinding sites mediate induction of the yeast major facilitator FLR1 gene in response to drugs, oxidants, and alkylating agents. J. Biol. Chem. 276:1138-1145.
52. Prasad, R., P. Dewergifosse, A. Goffeau, and E. Balzi. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:320-329.
53. Rao, U. S., and G. A. Scarborough. 1994. Direct demonstration of high affinity interactions of immunosuppressant drugs with the drug binding site of the human P-glycoprotein. Mol. Pharmacol. 45:773-776.
54. Raymond, M., P. Gros, M. Whiteway, and D. Y. Thomas. 1992. Functional complementation of yeast ste6 by a mammalian multidrug resistance mdr gene. Science 256:232-234.
55. Raymond, M., S. Ruetz, D. Y. Thomas, and P. Gros. 1994. Functional expression of P-glycoprotein in Saccharomyces cerevisiae confers cellular resistance to the immunosuppressive and antifungal agent FK520. Mol. Cell. Biol. 14:277-286.
56. Ruetz, S. 1998. Yeast secretory vesicle system for expression and functional characterization of P-glycoproteins. Methods Enzymol. 292:382-396.
57. Saeki, T., K. Ueda, Y. Tanigawara, R. Hori, and T. Komano. 1993. Human P-glycoprotein transports cyclosporin A and FK506. J. Biol. Chem. 268:6077-6080.
58. Safa, A. R. 1998. Photoaffinity labels for characterizing drug interaction sites of P-glycoprotein. Methods Enzymol. 292:289-307.
59. Safa, A. R., C. J. Glover, J. L. Sewell, M. B. Meyers, J. L. Biedler, and R. L. Felsted. 1987. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. J. Biol. Chem. 262:7884-7888.
60. Sanglard, D., F. Ischer, M. Monod, and J. Bille. 1997. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143:405-416.
61. Sanglard, D., K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
62. Santos, M. A. S., and M. F. Tuite. 1995. The CUG codon is decoded in vivo as serine and not leucine in Candida albicans. Nucleic Acids Res. 23:1481-1486.
63. Sherman, F. 1991. Getting started with yeast. Methods Enzymol. 194:3-21.
64. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
65. Smith, P. C., N. Karpowich, L. Millen, J. E. Moody, J. Rosen, P. J. Thomas, and J. F. Hunt. 2002. ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol. Cell 10:139-149.
66. Smriti, S. Krishnamurthy, B. L. Dixit, C. M. Gupta, S. Milewski, and R. Prasad. 2002. ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators. Yeast 19:303-318.
67. Taglicht, D., and S. Michaelis. 1997. A complete catalog of Saccharomyces cerevisiae ABC proteins and their relevance to human health and disease. Methods Enzymol. 292:130-162.
68. Talibi, D., and M. Raymond. 1999. Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae. J. Bacteriol. 181:231-240.
69. Tamai, I., and A. R. Safa. 1991. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells. J. Biol. Chem. 266:16796-16800.
70. Taylor, B. N., C. Fichtenbaum, M. Saavedra, I. J. Slavinsky, R. Swoboda, K. Wozniak, A. Arribas, W. Powderly, and P. L. Fidel, Jr. 2000. In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus. J. Infect. Dis. 182:955-959.
71. Urbatsch, I. L., M. Jullen, I. Carrier, M. E. Rousseau, R. Cayrol, and P. Gros. 2000. Mutational analysis of conserved carboxylate residues in the nucleotide binding sites of P-glycoprotein. Biochemistry 39:14138-14149.
72. Wang, E. J., K. Lew, C. N. Casciano, R. P. Clement, and W. W. Johnson. 2002. Interaction of common azole antifungals with P glycoprotein. Antimicrob. Agents Chemother. 46:160-165.
73. White, T. C. 1997. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41:1482-1487.
74. White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.